Berkshire Hathaway BMY trades
Warren Buffett
Warren Buffett Bristol-Myers Squibb Company stake
total: 135
Trades details
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 4
- Held since:
- 2020 Q3
- Held for:
- 6 quarters
- Latest activity:
- 2022 Q1
According to 2026 Q2 report, Warren Buffett doesn't hold any Bristol-Myers Squibb Company (BMY) shares. To date, the estimated cost basis is nearly $60.47 for "buy" trades and estimated average "sell" price is $62.63. Berkshire Hathaway first purchased BMY in 2020 Q3, initially acquiring about 29.97M shares. Since the initial investment in Bristol-Myers Squibb Company (BMY), Berkshire Hathaway has made 6 more transactions.
When did Warren Buffett sell Bristol-Myers Squibb Company (BMY)?
Warren Buffett sold off the entire Bristol-Myers Squibb Company (BMY) position in 2022 Q1.
When did Warren Buffett buy Bristol-Myers Squibb Company (BMY)?
Warren Buffett first invested in Bristol-Myers Squibb Company (BMY) in 2020 Q3 at the reported quarter-end price of $60.29 per share.
What's the cost basis of Berkshire Hathaway's BMY stake?
The estimated cost basis for Bristol-Myers Squibb Company (BMY) stake is around $60.47 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $60.47
- Weighted AVG sell price:
- $62.63
Warren Buffett's historical trades in Bristol-Myers Squibb Company
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q1
|
0.00%
|
0
|
$62.35
|
|
-100% (-5,202,674)
|
-0.1%
|
|
2021 Q4
|
0.10%
|
5,202,674
|
$62.35
|
$324,387,000
|
-76.40% (-16,844,262)
|
-0.36%
|
|
2021 Q3
|
0.44%
|
22,046,936
|
$59.17
|
$1,304,517,000
|
-16.15% (-4,247,330)
|
-0.09%
|
|
2021 Q2
|
0.60%
|
26,294,266
|
$66.82
|
$1,756,983,000
|
-15.27% (-4,737,961)
|
-0.12%
|
|
2021 Q1
|
0.72%
|
31,032,227
|
$63.13
|
$1,959,064,000
|
-6.91% (-2,303,789)
|
-0.05%
|
|
2020 Q4
|
0.77%
|
$62.03
|
+11.23% (+3,364,822)
|
|||
|
2020 Q3
|
0.77%
|
$60.29
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.